Provided By PR Newswire
Last update: Sep 26, 2025
MINNEAPOLIS, Sept. 26, 2025 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH), a global provider of life science tools, reagents and diagnostic products, today announced new advancements in its spatial biology portfolio for the RNAscope⢠ISH technology and the Lunaphore COMETā¢. These solutions help researchers and pathologists bridge the gap between translational research and clinical applications by enabling the detection of RNA and protein biomarkers on the same tissue section.
Read more at prnewswire.com58.73
+0.92 (+1.59%)
Find more stocks in the Stock Screener


